Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Stand & Move at Work

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02566317
Recruitment Status : Completed
First Posted : October 2, 2015
Results First Posted : October 11, 2019
Last Update Posted : October 11, 2019
Sponsor:
Collaborator:
University of Minnesota
Information provided by (Responsible Party):
Arizona State University

Brief Summary:
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.

Condition or disease Intervention/treatment Phase
Obesity Hypertension Diabetes Device: Sit-Stand workstation Behavioral: Move Not Applicable

Detailed Description:
With traditional approaches to increasing MVPA (moderate to vigorous physical activity) in the workplace being unsustainable due to the requirement of deliberate and dedicated time away from work, this group-randomized trial will test the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity (LPA) in a highly generalizable sample of office worksites using a multi-level intervention with high potential for dissemination.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 630 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Stand & Move at Work: A Group Randomized Trial
Actual Study Start Date : January 15, 2016
Actual Primary Completion Date : December 15, 2017
Actual Study Completion Date : December 15, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Move
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace.
Behavioral: Move
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace

Experimental: Stand & Move
Move intervention (A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace) plus the installation of a sit-stand workstation.
Device: Sit-Stand workstation
Installation of a sit-stand desk at work

Behavioral: Move
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace




Primary Outcome Measures :
  1. Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months [ Time Frame: 1 year ]
    Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)

  2. Mean Change in Sitting Time at Work From Baseline to 12 Months [ Time Frame: 1 year ]
    Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)


Secondary Outcome Measures :
  1. Clustered Metabolic Risk Score From Baseline to 12 Months [ Time Frame: 1 year ]
    Clustered metabolic risk score (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure); value at 12 months minus value at baseline; higher scores indicate better outcome. The Z-score for each component (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure) based on the baseline mean and standard deviation of the entire group was computed and summed for each participant (HDL z-score was subtracted rather than added). The sum of these z-scores represents the metabolic risk score.


Other Outcome Measures:
  1. Sleep Substudy [ Time Frame: 1 year ]
    24h wrist accelerometry in individuals with minor-moderate sleep complaints

  2. Ambulatory Blood Pressure [ Time Frame: 3 months ]
    Dynamic changes in ambulatory blood pressure in prehypertensives

  3. Ecological Momentary Assessment of Mood [ Time Frame: 1 year ]
    Periodic monitoring of mood, energy, fatigue in smartphone users

  4. Dynamic Glucose Control [ Time Frame: 3 months ]
    Continuous glucose monitoring in prediabetics



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Worksite-level inclusion criteria:

  • Size: Small to moderate size worksite (20-60 employees)
  • Schedule: >80% of employees full time
  • Occupation: Seated office work, primarily computer- and- telephone-based work, little movement or walking
  • Wellness environment: Not currently undergoing a wellness program aimed at increasing activity at work
  • Workstations: Willing to have sit-stand workstations installed at a worksite
  • Willing to be randomized: Willing to be randomized to either intervention conditions

Member-level inclusion criteria:

  • Age: 18 years and older
  • Health status: Generally good health and able to safely increase LPA and reduce sitting time
  • Employment status: Any sedentary job, sitting most of the say, little standing or walking
  • Occupation: Traditional sitting desk, willing to have a sit-stand workstation installed at desk
  • Workstation: traditional sitting desk;willing to have a sit-stand workstation installed at desk

Exclusion Criteria:

  • contraindication to prolonged standing at work

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02566317


Locations
Layout table for location information
United States, Arizona
Arizona State University
Tempe, Arizona, United States, 85281
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
Arizona State University
University of Minnesota
Investigators
Layout table for investigator information
Principal Investigator: Matthew P Buman, PhD Arizona State University
Principal Investigator: Mark A Pereira, PhD University of Minnesota
  Study Documents (Full-Text)

Documents provided by Arizona State University:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Arizona State University
ClinicalTrials.gov Identifier: NCT02566317    
Other Study ID Numbers: R01CA198971 ( U.S. NIH Grant/Contract )
First Posted: October 2, 2015    Key Record Dates
Results First Posted: October 11, 2019
Last Update Posted: October 11, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases